Table 2 Changes in TILs and CD8+ T cells following NAC
|  | Pre-NAC cohort (n = 6) | Post-NAC cohort (n = 17) |
|---|---|---|
Percentage of TILs | ||
 Stromal TILs | 29.8% (1–80%) | 24.9% (2–70%) |
Percentage of CD8+ T cells | ||
 Overall CD8+ T cells | 18.3% (0.5–60%) | 15.7% (1–50%) |
 Stromal CD8+ T cells | 24.6% (1–70%) | 21.2% (1–60%) |
 Intratumoral CD8+ T cells | 12.0% (0–50%) | 7.9% (0–40%) |